Conference ReportsNanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier
References and Notes (21)
- et al.
Drug delivery through the blood-brain barrier
Adv. Drug Del. Rev.
(1996) - et al.
Reversible association of the cytokines MIP-1α and MIP-1β with the endothelia of the blood-brain barrier
Neurosci. Lett.
(1996) - et al.
Comparison of saturable transport and extracellular pathways in the passage of interleukin-1R across the blood-brain barrier
J. Neuroimmunol.
(1996) - et al.
Targeted delivery of DANN by liposomes and polymers
J. Controlled Release
(1992) - et al.
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Brain Res.
(1995) - et al.
Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants
Int. J. Pharm.
(1990) - et al.
Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier
Peptides
(1998) - et al.
Simultaneous determination of amitriptyline, nortriptyline and 4 hydroxylated metabo-lites in serum by capillary gas-liquid chromatography with nitrogen-phosphorus selective detection
J. Chromatogr. B.
(1996) - et al.
Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections
Brain Res.
(1996) Modulation of blood-brain barrier permeability
J. Drug Target.
(1996)
There are more references available in the full text version of this article.
Cited by (278)
Targeted nanomedicine: Lessons learned and future directions
2023, Journal of Controlled ReleaseNanocarrier-mediated delivery for targeting for prostate cancer
2023, Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer TherapyNanomedicines encountering HIV dementia: A guiding star for neurotherapeutics
2022, Journal of Drug Delivery Science and TechnologyNano therapeutic approaches to combat progression of metastatic prostate cancer
2021, Advances in Cancer Biology - MetastasisMetallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives
2021, Journal of Trace Elements in Medicine and Biology
Copyright © 1998 Wiley-Liss, Inc., A Wiley Company. Published by Elsevier Inc. All rights reserved.